Jose Antonio Sanchez-Tomero
Overview
Explore the profile of Jose Antonio Sanchez-Tomero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avila-Carrasco L, Majano P, Sanchez-Tomero J, Selgas R, Lopez-Cabrera M, Aguilera A, et al.
Front Pharmacol
. 2019 Aug;
10:715.
PMID: 31417401
Epithelial-to-mesenchymal transition (EMT) is a self-regulated physiological process required for tissue repair that, in non-controled conditions may lead to fibrosis, angiogenesis, loss of normal organ function or cancer. Although several...
2.
Nogueira A, Alvarez G, Russo F, San-Jose B, Sanchez-Tomero J, Barril G
Nefrologia (Engl Ed)
. 2019 Apr;
39(5):489-496.
PMID: 30971342
Introduction And Objective: One of the consequences of the CKD, is the deterioration of the functional capacity, being able to manifest from different stages of the disease, until renal replacement...
3.
Barril G, Nogueira A, Ruperto Lopez M, Castro Y, Sanchez-Tomero J
Nefrologia (Engl Ed)
. 2018 Oct;
38(6):647-654.
PMID: 30293714
Introduction: A controlled protein intake has shown beneficial effects to preserve renal function and nutritional status in chronic kidney disease (CKD) patients. This study aimed to analyze usual dietary protein...
4.
Ruiz-Carpio V, Sandoval P, Aguilera A, Albar-Vizcaino P, Perez-Lozano M, Gonzalez-Mateo G, et al.
Sci Rep
. 2017 Mar;
7:44941.
PMID: 28327551
Peritoneal dialysis (PD) is an effective renal replacement therapy, but a significant proportion of patients suffer PD-related complications, which limit the treatment duration. Mesothelial-to-mesenchymal transition (MMT) contributes to the PD-related...
5.
Liappas G, Gonzalez-Mateo G, Majano P, Sanchez-Tomero J, Ruiz-Ortega M, Rodrigues Diez R, et al.
Biomed Res Int
. 2017 Mar;
2017:6130208.
PMID: 28271068
[This corrects the article DOI: 10.1155/2015/416480.].
6.
Gonzalez-Mateo G, Aguirre A, Loureiro J, Abensur H, Sandoval P, Sanchez-Tomero J, et al.
Biomed Res Int
. 2015 Dec;
2015:989560.
PMID: 26688823
Preservation of peritoneal membrane (PM) is essential for long-term survival in peritoneal dialysis (PD). Continuous presence of PD fluids (PDF) in the peritoneal cavity generates chronic inflammation and promotes changes...
7.
Peso G, Jimenez-Heffernan J, Selgas R, Remon C, Ossorio M, Fernandez-Perpen A, et al.
Perit Dial Int
. 2015 Oct;
36(2):129-34.
PMID: 26475848
Unlabelled: ♦ Introduction: Chronic exposure to conventional peritoneal dialysis (PD) solutions has been related to peritoneal function alterations in PD patients, and associated with mesothelial cell loss, submesothelial fibrosis, vasculopathy,...
8.
Salanova-Villanueva L, Bernis-Carro C, Alberto-Blazquez L, Sanchez-Tomero J
Nefrologia
. 2015 Aug;
35(3):334-6.
PMID: 26299178
No abstract available.
9.
Liappas G, Gonzalez-Mateo G, Majano P, Sanchez-Tomero J, Ruiz-Ortega M, Rodrigues Diez R, et al.
Biomed Res Int
. 2015 Jun;
2015:416480.
PMID: 26064907
Fibrosis is a general complication in many diseases. It is the main complication during peritoneal dialysis (PD) treatment, a therapy for renal failure disease. Local inflammation and mesothelial to mesenchymal...
10.
Godino M, Romera V, Sanchez-Tomero J, Pacheco J, Canals S, Lerma J, et al.
J Clin Invest
. 2013 Sep;
123(10):4359-63.
PMID: 23999426
Ischemic stroke is a devastating condition, for which there is still no effective therapy. Acute ischemic stroke is associated with high concentrations of glutamate in the blood and interstitial brain...